MAPT and Alzheimer disease: The pathological criteria for AD, or MCI due to AD, includes neuropathological evidence of neurofibrillary tangles and senile plaques with extracellular β-amyloid (Aβ) deposition and abnormal total tau (t-tau) or phosphorylated-tau (p-tau) deposition [4].